<DOC>
	<DOCNO>NCT00912847</DOCNO>
	<brief_summary>The purpose study : 1 . To establish compare diagnostic utility hepatocellular carcinoma ( HCC ) screening test ( ) HS-AFP , ( b ) AFP + US , ( c ) AFP alone ( ) US alone ( within HBV carrier age 40 70 year ) ; 2 . To establish cost-effectiveness screening test ; 3 . To compare tumor size , resection rate , survival rate 18 month screen HS-AFP historical control group screen .</brief_summary>
	<brief_title>Validity Cost-Effectiveness New Screening Test Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Age 40 70 year Seropositive HBsAg Child 's A B Life expectancy 2 year NonHBV relate cirrhosis History malignancy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>HBV carrier</keyword>
</DOC>